(PDF) Prs71 - Wasteful Healthcare Spending on Medication

Prs71 - Wasteful Healthcare Spending on Medication Oversupply in Routine Uses of Combined Inhaled Corticosteroid and Long-Acting Beta2-Agonists (Ics/Laba) Inhalers

Value in Health - United Kingdom

doi 10.1016/j.jval.2018.09.2465

Full Text

Open PDF

Abstract

Available in full text

Date

October 1, 2018

Authors

P. Tanvejsilp

C. Nilmoje

K. Sukhsawat

Publisher

Elsevier BV

Related search

Prs34 - Cost and Drug Utilization Trends in Inhaled Corticosteroids/Long-Acting Beta Agonists (Ics/Laba) Fixed-Dose Combinations in Spain

English

Addition of Long-Acting Beta2-Agonists to Inhaled Corticosteroids Versus Same Dose Inhaled Corticosteroids for Chronic Asthma in Adults and Children

Cochrane Database of Systematic Reviews

2010

English

Severe Exacerbation and Pneumonia in COPD Patients Treated With Fixed Combinations of Inhaled Corticosteroid and Long-Acting Beta2 Agonist

International Journal of COPD

English

PRS30 Inhaled Corticosteroid and Long-Acting Beta-Agonist Medication Compliance in Patients With Moderate and Severe Asthma

English

Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients With COPD: Pooled Results of Randomized Placebo-Controlled Trials

Pulmonary Therapy

2016

English

Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist

Pulmonary Therapy

2016

English

Combination Long-Acting Β-Agonists and Inhaled Corticosteroids Compared With Long-Acting Β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease

JAMA - Journal of the American Medical Association

Medicine

2014

English

Effect of Short- And Long-Acting Inhaled Β2-Agonists on Exhaled Nitric Oxide in Asthmatic Patients

European Respiratory Journal

English

The Debate About the Use of Long-Acting Inhaled ß-Agonists in Asthma

Barcelona Respiratory Network

2017

English

Amanote Research

Prs71 - Wasteful Healthcare Spending on Medication Oversupply in Routine Uses of Combined Inhaled Corticosteroid and Long-Acting Beta2-Agonists (Ics/Laba) Inhalers

Value in Health - United Kingdom

doi 10.1016/j.jval.2018.09.2465

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Prs34 - Cost and Drug Utilization Trends in Inhaled Corticosteroids/Long-Acting Beta Agonists (Ics/Laba) Fixed-Dose Combinations in Spain

Addition of Long-Acting Beta2-Agonists to Inhaled Corticosteroids Versus Same Dose Inhaled Corticosteroids for Chronic Asthma in Adults and Children

Severe Exacerbation and Pneumonia in COPD Patients Treated With Fixed Combinations of Inhaled Corticosteroid and Long-Acting Beta2 Agonist

PRS30 Inhaled Corticosteroid and Long-Acting Beta-Agonist Medication Compliance in Patients With Moderate and Severe Asthma

Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients With COPD: Pooled Results of Randomized Placebo-Controlled Trials

Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist

Combination Long-Acting Β-Agonists and Inhaled Corticosteroids Compared With Long-Acting Β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease

Effect of Short- And Long-Acting Inhaled Β2-Agonists on Exhaled Nitric Oxide in Asthmatic Patients

The Debate About the Use of Long-Acting Inhaled ß-Agonists in Asthma

Amanote Research

Prs71 - Wasteful Healthcare Spending on Medication Oversupply in Routine Uses of Combined Inhaled Corticosteroid and Long-Acting Beta2-Agonists (Ics/Laba) Inhalers

Value in Health - United Kingdom

doi 10.1016/j.jval.2018.09.2465

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Prs34 - Cost and Drug Utilization Trends in Inhaled Corticosteroids/Long-Acting Beta Agonists (Ics/Laba) Fixed-Dose Combinations in Spain

Addition of Long-Acting Beta2-Agonists to Inhaled Corticosteroids Versus Same Dose Inhaled Corticosteroids for Chronic Asthma in Adults and Children

Severe Exacerbation and Pneumonia in COPD Patients Treated With Fixed Combinations of Inhaled Corticosteroid and Long-Acting Beta2 Agonist

PRS30 Inhaled Corticosteroid and Long-Acting Beta-Agonist Medication Compliance in Patients With Moderate and Severe Asthma

Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients With COPD: Pooled Results of Randomized Placebo-Controlled Trials

Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist

Combination Long-Acting Β-Agonists and Inhaled Corticosteroids Compared With Long-Acting Β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease

Effect of Short- And Long-Acting Inhaled Β2-Agonists on Exhaled Nitric Oxide in Asthmatic Patients

The Debate About the Use of Long-Acting Inhaled &#223;-Agonists in Asthma

The Debate About the Use of Long-Acting Inhaled ß-Agonists in Asthma